Literature DB >> 24163745

Screening for lung cancer with low-dose computed tomography: a review of current status.

Henry M Marshall1, Rayleen V Bowman, Ian A Yang, Kwun M Fong, Christine D Berg.   

Abstract

Screening using low-dose computed tomography (CT) represents an exciting new development in the struggle to improve outcomes for people with lung cancer. Randomised controlled evidence demonstrating a 20% relative lung cancer mortality benefit has led to endorsement of screening by several expert bodies in the US and funding by healthcare providers. Despite this pivotal result, many questions remain regarding technical and logistical aspects of screening, cost-effectiveness and generalizability to other settings. This review discusses the rationale behind screening, the results of on-going trials, potential harms of screening and current knowledge gaps.

Entities:  

Keywords:  Lung neoplasms/mortality; early detection of cancer/methods; helical computed; mass screening tomography

Year:  2013        PMID: 24163745      PMCID: PMC3804881          DOI: 10.3978/j.issn.2072-1439.2013.09.06

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  131 in total

1.  Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.

Authors:  Rebecca M Lindell; Thomas E Hartman; Stephen J Swensen; James R Jett; David E Midthun; Henry D Tazelaar; Jayawant N Mandrekar
Journal:  Radiology       Date:  2007-02       Impact factor: 11.105

2.  Does 2-year stability imply that pulmonary nodules are benign?

Authors:  D F Yankelevitz; C I Henschke
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

3.  Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial.

Authors:  Mario Mascalchi; Giacomo Belli; Marco Zappa; Giulia Picozzi; Massimo Falchini; Riccardo Della Nave; Germana Allescia; Andrea Masi; Andrea Lopes Pegna; Natale Villari; Eugenio Paci
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

4.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

5.  Cancer survival in Africa, Asia, and Central America: a population-based study.

Authors:  Rengaswamy Sankaranarayanan; Rajaraman Swaminathan; Hermann Brenner; Kexin Chen; Kee Seng Chia; Jian Guo Chen; Stephen C K Law; Yoon-Ok Ahn; Yong Bing Xiang; Balakrishna B Yeole; Hai Rim Shin; Viswanathan Shanta; Ze Hong Woo; Nimit Martin; Yupa Sumitsawan; Hutcha Sriplung; Adolfo Ortiz Barboza; Sultan Eser; Bhagwan M Nene; Krittika Suwanrungruang; Padmavathiamma Jayalekshmi; Rajesh Dikshit; Henry Wabinga; Divina B Esteban; Adriano Laudico; Yasmin Bhurgri; Ebrima Bah; Nasser Al-Hamdan
Journal:  Lancet Oncol       Date:  2009-12-10       Impact factor: 41.316

Review 6.  Overview and strategic management of subsolid pulmonary nodules.

Authors:  Myrna C B Godoy; David P Naidich
Journal:  J Thorac Imaging       Date:  2012-07       Impact factor: 3.000

Review 7.  Screening for lung cancer.

Authors:  R L Manser; L B Irving; C Stone; G Byrnes; M Abramson; D Campbell
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk.

Authors:  Amy Berrington de González; Kwang Pyo Kim; Christine D Berg
Journal:  J Med Screen       Date:  2008       Impact factor: 2.136

9.  The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan.

Authors:  David O Wilson; Joel L Weissfeld; Carl R Fuhrman; Stephen N Fisher; Paula Balogh; Rodney J Landreneau; James D Luketich; Jill M Siegfried
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

Review 10.  Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.

Authors:  A Parsons; A Daley; R Begh; P Aveyard
Journal:  BMJ       Date:  2010-01-21
View more
  25 in total

1.  Early screening of lung cancers: an effort arduous but worthwhile.

Authors:  Chu Pei; Lawrence Grouse; Guangqiao Zeng
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

2.  Solitary peribronchiolar metaplasia showing a sub-solid nodule on computed tomography.

Authors:  Yoshiyuki Yasuura; Hiroyuki Kayata; Kiyomichi Mizuno; Naoko Miyata; Hideaki Kojima; Mitsuhiro Isaka; Ichiro Ito; Yasuhisa Ohde; Masahiro Endo; Takashi Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-26

3.  Lung cancer.

Authors:  Kwun M Fong
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 4.  Management strategy of solitary pulmonary nodules.

Authors:  Ping Zhan; Haiyan Xie; Chunhua Xu; Keke Hao; Zhibo Hou; Yong Song
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

5.  CYP1A2 rs2069514 polymorphism and lung cancer susceptibility: a meta-analysis.

Authors:  Wenlong Shao; Jianxing He
Journal:  Ann Transl Med       Date:  2015-05

6.  Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program.

Authors:  Mariann Moizs; Gábor Bajzik; Zsuzsanna Lelovics; János Strausz; Marianna Rakvács; Péter Zádori; Árpád Kovács; Imre Repa
Journal:  Pathol Oncol Res       Date:  2015-05-25       Impact factor: 3.201

7.  Lung cancer screening with ultra-low dose CT using full iterative reconstruction.

Authors:  Masayo Fujita; Toru Higaki; Yoshikazu Awaya; Toshio Nakanishi; Yuko Nakamura; Fuminari Tatsugami; Yasutaka Baba; Makoto Iida; Kazuo Awai
Journal:  Jpn J Radiol       Date:  2017-02-14       Impact factor: 2.374

8.  Diagnostic value of computed tomography scanning in differentiating malignant from benign solitary pulmonary nodules: a meta-analysis.

Authors:  Chuan-Yu Zhang; Hua-Long Yu; Xia Li; Yong-Ye Sun
Journal:  Tumour Biol       Date:  2014-05-26

9.  Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study.

Authors:  Giselle K Perez; Ilana F Gareen; JoRean Sicks; Christopher Lathan; Alaina Carr; Pallavi Kumar; Colin Ponzani; Kelly Hyland; Elyse R Park
Journal:  J Racial Ethn Health Disparities       Date:  2019-02-08

10.  Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.

Authors:  Guiping Yu; Ning Zhong; Guoqiang Chen; Bin Huang; Song Wu
Journal:  Tumour Biol       Date:  2014-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.